Your session is about to expire
← Back to Search
Neuromodulation Device
overactive bladder patients for Overactive Bladder
N/A
Waitlist Available
Research Sponsored by Loma Linda University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Summary
The purpose of this investigator-initiated study is to investigate the efficacy and costs of direct full stage sacral neuromodulation in patients with overactive bladder. Patients with refractory OAB and urge urinary incontinence will undergo direct full stage implantation and be followed for a period of 6 months to monitor symptom improvement with voiding diaries and validated questionnaires preoperatively and postoperatively. Therapeutic and adverse outcomes will be evaluated. The use of medical resources and time off of work will be analyzed as well. This will be a descriptive study with no additional arms or randomization.
Eligible Conditions
- Overactive Bladder
- Urge Incontinence
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Improvement in overactive bladder symptoms
Trial Design
1Treatment groups
Experimental Treatment
Group I: overactive bladder patientsExperimental Treatment1 Intervention
Female patients with refractory overactive bladder and urge urinary incontinence undergoing direct full stage implantation
Find a Location
Who is running the clinical trial?
Loma Linda UniversityLead Sponsor
314 Previous Clinical Trials
266,521 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger